Literature DB >> 4860146

Sparsomycin inhibition of polypeptide synthesis promoted by synthetic and natural polynucleotides.

I H Goldberg, K Mitsugi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4860146     DOI： 10.1021/bi00854a002

Source DB:  PubMed          Journal:  Biochemistry        ISSN： 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  10 in total

1.  Inhibitors of protein synthesis V. Irreversible interaction of antibiotics with an initiation complex.

Authors:  C Coutsogeorgopoulos; J T Miller; D M Hann
Journal:  Nucleic Acids Res       Date:  1975-07       Impact factor: 16.971

2.  Control of eIF-2 phosphatase activity in rabbit reticulocyte lysate.

Authors:  B Safer; R Jagus
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

3.  Effect of ribosomal wash factors on inhibition by chloramphenicol.

Authors:  H J Cameron; S M Rogers; G R Julian
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

4.  Rapid inhibition of polypeptide chain extension by streptomycin.

Authors:  J Modolell; B D Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1968-12       Impact factor: 11.205

5.  Requirement of granosine 5'-triphosphate for ribosomal binding of aminoacyl-SRNA.

Authors:  J Lucas-Lenard; A L Haenni
Journal:  Proc Natl Acad Sci U S A       Date:  1968-02       Impact factor: 11.205

Review 6.  Mechanism of protein biosynthesis.

Authors:  P Lengyel; D Söll
Journal:  Bacteriol Rev       Date:  1969-06

7.  Effect of sparsomycin on protein synthesis in the mouse liver.

Authors:  A C Trakatellis
Journal:  Proc Natl Acad Sci U S A       Date:  1968-03       Impact factor: 11.205

8.  Binding of puromycin to E. coli ribosomes. Effects of puromycin analogues and peptide bond formation inhibitors.

Authors:  R Fernandez-Muñoz; D Vazquez
Journal:  Mol Biol Rep       Date:  1973-06       Impact factor: 2.316

9.  In vitro synthesis of Trypanosoma cruzi antigenic polypeptides.

Authors:  A M Stolf; C L Santos; R Brentani; M E Camargo
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

10.  Preclinical antitumor activity of ethyldeshydroxysparsomycin in combination with cisplatin.

Authors:  H P Hofs; D J Wagener; V De Valk-Bakker; H Van Rennes; D De Vos; W H Doesburg; H C Ottenheijm; W J De Grip
Journal:  Invest New Drugs       Date:  1995       Impact factor: 3.850
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.